الفهرس 
Aim of the workOnly 14 pages are availabe for public view
 |  | from | 16 |  |  |
| | | from | 16 | | |
Abstract
A substantial amount of experience supports the use of imaging-guided radiofrequency ablation in the treatment of primary RCC. Because surgical resection is a technique with low mortality and a proved success rate that is high, surgery must remain standard therapy for patients with potentially curable RCC. However, some patients with early-stage RCC may not be surgical candidates.
Imaging-guided radiofrequency ablation is an option for treatment in these patients. It appears this technique has a low complication rate, preserves renal function, is well tolerated by patients, and, in a high percentage of patients, can eradicate small renal tumors. In addition, imaging-guided radiofrequency ablation shows promise for the successful care of other patients with RCC. In particular, radiofrequency ablation has been used successfully in the treatment of refractory hematuria resulting from RCC, of local recurrence of RCC, and, finally, of isolated metastases from RCC. As with the treatment of primary RCC, the data remain limited for these applications; therefore, this technique should be reserved until standard therapies have been exhausted.
The use of radiofrequency ablation for the treatment of RCC is a very promising technique that should be considered a treatment option for patients with early-stage RCC who are poor surgical candidates. The use of radiofrequency ablation for the treatment of RCC is a very promising technique that should be considered a treatment option for patients with early-stage RCC who are poor surgical candidates.
Conducting an ablation program requires a commitment to understanding the diagnosis and staging of renal cell carcinomas, acquiring the skills for ablative techniques, correctly interpreting the imaging after ablation, and closely following patients after treatment.